IONS - Ionis Pharmaceuticals enters into a license agreement with Otsuka
2023-12-18 16:05:26 ET
More on Ionis Pharmaceuticals
- Ionis Pharmaceuticals: Pioneering Precision Medicine
- Ionis says Angelman syndrome drug well tolerated in study
- Ionis Pharmaceuticals GAAP EPS of -$1.03 in-line, revenue of $144M beats by $7.62M
For further details see:
Ionis Pharmaceuticals enters into a license agreement with Otsuka